Literature DB >> 18041408

Regeneration of the skeleton by recombinant human bone morphogenetic proteins.

Tomislav Smoljanović1, Lovorka Grgurević, Mislav Jelić, Mario Kreszinger, Miroslav Haspl, Drazen Maticić, Slobodan Vukicević, Marko Pećina.   

Abstract

Recombinant human bone morphogenetic proteins (rhBMPs) have past a long journey in human orthopaedic surgery during the last 15 years. From the first reports of the use of rhBMPs in hostile environments such as critically-sized bone defects, avascular femoral head necrosis, unstable thoracolumbar vertebral fractures, instability between the atlas and axis due to rheumatoid arthritis; over the use for nonunions of long bones and the scaphoid, reconstructive and revision surgeries of the hip, acute fractures, allograft nonunions, congenital pseudarthrosis, and various approaches of lumbar and cervical spine fusions, rhBMPs overgrow to a safe and reliable device in the treatment of open tibial shaft fractures, nonunions of long bone fractures, anterior lumbar interbody fusion and revision posterolateral lumbar fusions. Systematic review of the published literature of rhBMPs is presented.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18041408

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  3 in total

1.  Adverse effects of posterior lumbar interbody fusion using rhBMP-2.

Authors:  Tomislav Smoljanovic; Ivan Bojanic; Domagoj Delimar
Journal:  Eur Spine J       Date:  2009-04-08       Impact factor: 3.134

2.  Bone regeneration in ceramic scaffolds with variable concentrations of PDRN and rhBMP-2.

Authors:  Ho-Kyung Lim; Yeh-Jin Kwon; Seok-Jin Hong; Hyo-Geun Choi; Sung-Min Chung; Byoung-Eun Yang; Jong-Ho Lee; Soo-Hwan Byun
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

Review 3.  Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications.

Authors:  Thanavel Rajangam; Seong Soo A An
Journal:  Int J Nanomedicine       Date:  2013-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.